2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-09-01 Sage Accounts Production Advanced 2024 - FRS102_2024 13,984 13,983 1 1 xbrli:pure xbrli:shares iso4217:GBP 02956887 2024-09-01 2025-08-31 02956887 2025-08-31 02956887 2024-08-31 02956887 2023-09-01 2024-08-31 02956887 2024-08-31 02956887 2023-08-31 02956887 core:PlantMachinery 2024-09-01 2025-08-31 02956887 bus:Director2 2024-09-01 2025-08-31 02956887 bus:Director1 2024-09-01 2025-08-31 02956887 core:PlantMachinery 2025-08-31 02956887 core:WithinOneYear 2025-08-31 02956887 core:WithinOneYear 2024-08-31 02956887 core:AfterOneYear 2025-08-31 02956887 core:AfterOneYear 2024-08-31 02956887 core:ShareCapital 2025-08-31 02956887 core:ShareCapital 2024-08-31 02956887 core:RetainedEarningsAccumulatedLosses 2025-08-31 02956887 core:RetainedEarningsAccumulatedLosses 2024-08-31 02956887 core:PlantMachinery 2024-08-31 02956887 bus:Director1 2024-08-31 02956887 bus:Director1 2025-08-31 02956887 bus:Director2 2024-08-31 02956887 bus:Director2 2025-08-31 02956887 bus:Director1 2023-08-31 02956887 bus:Director1 2024-08-31 02956887 bus:Director2 2023-08-31 02956887 bus:Director2 2024-08-31 02956887 bus:Director1 2023-09-01 2024-08-31 02956887 bus:Director2 2023-09-01 2024-08-31 02956887 bus:SmallEntities 2024-09-01 2025-08-31 02956887 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 02956887 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 02956887 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 02956887 bus:FullAccounts 2024-09-01 2025-08-31
COMPANY REGISTRATION NUMBER: 02956887

Strategic Health Limited

Filleted Unaudited Financial Statements

31 August 2025

Strategic Health Limited

Statement of Financial Position

31 August 2025

| 2025 | 2024
Note | £ | £ | £

Fixed assets

Tangible assets | 5 |  | 1 | 1

Current assets

Debtors | 6 | 32,029 |  | 18,376
Cash at bank and in hand | 18,242 |  | 29,741
| -------- |  | --------
| 50,271 |  | 48,117

Creditors: amounts falling due within one year | 7 | 49,237 |  | 39,896
| -------- |  | --------
Net current assets |  | 1,034 | 8,221
|  | ------- | -------
Total assets less current liabilities |  | 1,035 | 8,222

Creditors: amounts falling due after more than one year | 8 |  | 904 | 8,027
|  | ------- | -------
Net assets |  | 131 | 195
|  | ------- | -------

Capital and reserves

Called up share capital |  | 100 | 100
Profit and loss account |  | 31 | 95
|  | ---- | ----
Shareholders funds |  | 131 | 195
|  | ---- | ----

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Strategic Health Limited

Statement of Financial Position (continued)

31 August 2025
These financial statements were approved by the board of directors and authorised for issue on 6 May 2026 , and are signed on behalf of the board by:

Dr T J Anstiss
Director

Company registration number: 02956887

Strategic Health Limited

Notes to the Financial Statements

Year ended 31 August 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 26 Lossie Drive, Iver, Bucks, SL0 0JS.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Equipment | - | 25% reducing balance

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
5. Tangible assets

| Plant and machinery | Total
| £ | £
Cost |  |
At 1 September 2024 and 31 August 2025 | 13,984 | 13,984
| -------- | --------
Depreciation |  |
At 1 September 2024 and 31 August 2025 | 13,983 | 13,983
| -------- | --------
Carrying amount |  |
At 31 August 2025 | 1 | 1
| -------- | --------
At 31 August 2024 | 1 | 1
| -------- | --------

6. Debtors

| 2025 | 2024
| £ | £
Trade debtors | 5,458 | 7,791
Other debtors | 26,571 | 10,585
| -------- | --------
| 32,029 | 18,376
| -------- | --------

7. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Bank loans and overdrafts | 7,000 | 7,000
Corporation tax | 35,963 | 27,841
Social security and other taxes | 6,274 | 5,055
| -------- | --------
| 49,237 | 39,896
| -------- | --------

8. Creditors: amounts falling due after more than one year

| 2025 | 2024
| £ | £
Bank loans and overdrafts | 904 | 8,027
| ---- | -------

9. Directors' advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:

| 2025
|  | Balance brought forward | Advances/ (credits) to the directors | Amounts repaid | Balance outstanding
|  | £ | £ | £ | £
| Mrs K M Anstiss | 5,293 | 7,993 | – | 13,286
| Dr T J Anstiss | 5,292 | 7,993 | – | 13,285
|  | -------- | -------- | ---- | --------
|  | 10,585 | 15,986 | – | 26,571
|  | -------- | -------- | ---- | --------

| 2024
|  | Balance brought forward | Advances/ (credits) to the directors | Amounts repaid | Balance outstanding
|  | £ | £ | £ | £
| Mrs K M Anstiss | 7,235 | – | ( 1,942) | 5,293
| Dr T J Anstiss | 7,235 | – | ( 1,943) | 5,292
|  | -------- | ---- | ------- | --------
|  | 14,470 | – | ( 3,885) | 10,585
|  | -------- | ---- | ------- | --------

10. Related party transactions
The company was under the control of Dr T J Anstiss and Mrs K M Anstiss throughout the current and previous year. They are both directors and equal shareholders. No transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard for Smaller Entities (effective April 2008).